11 of the ETFs we track hold AbbVie Inc in their latest SEC N-PORT filings — ranked by each fund’s portfolio weight in the name.
By portfolio weight, as of each fund’s latest public N-PORT.
| ETF | Weight in ABBV | Value | As of |
|---|---|---|---|
| XLV | 7.25% | $2.80B | 2026-03-31 |
| SCHD | 3.53% | $3.03B | 2026-02-28 |
| VIG | 1.68% | $2.10B | 2026-04-30 |
| VTV | 1.58% | $3.56B | 2026-03-31 |
| VYM | 1.56% | $1.48B | 2026-04-30 |
| IWF | 1.39% | $1.55B | 2026-03-31 |
| XBI | 1.09% | $80.9M | 2026-03-31 |
| VOO | 0.69% | $9.77B | 2026-03-31 |
| SPY | 0.69% | $4.48B | 2026-03-31 |
| IVV | 0.69% | $4.94B | 2026-03-31 |
| VTI | 0.61% | $12.2B | 2026-03-31 |
Want the other side? See the full book of any fund above on the ETF holdings directory, or go back to ABBV’s full analysis.
Source: SEC Form N-PORT-P — each fund’s latest public fiscal-quarter-end report, filed ~2 months after the period. Weight is the ETF’s percent of assets in ABBV; value is as reported in the filing. A delayed, roughly quarterly snapshot, not a live position. Covers only the large/liquid ETFs we track, and only holdings that resolve to a ticker — a fund missing here may still hold ABBV. No market-price data is used.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.